Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Filings indexed 752 across all filing types
Latest filing 2022-05-04 AGM Information
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting 2022
AGM Information Classification · 95% confidence The document is titled 'Innstilling fra Valgkomitéen' (Proposal from the Nomination committee) for PCI Biotech Holding ASA, dated May 25, 2022. It details the committee's work, proposes the re-election of the entire board of directors, and suggests remuneration for the board and the nomination committee for the upcoming year, leading up to the Annual General Meeting (AGM). This content is directly related to the preparation and proposals for the AGM, specifically concerning board composition and compensation, which falls under the scope of AGM materials or related governance/remuneration documents. Since it is a formal proposal *for* the AGM regarding board elections, it is most closely aligned with the materials presented or discussed at the AGM, or the governance structure leading up to it. Given the options, 'AGM-R' (AGM Information) is the most appropriate fit as it concerns the election process and proposals for the general meeting. It is not a DEF 14A (Remuneration Information) because it covers board composition as well, nor is it CGR (Governance Information) as it is a specific, time-bound proposal for an upcoming vote.
2022-05-04 English
Notice of Annual General Meeting 2022
Remuneration Information Classification · 98% confidence The document is explicitly titled "PCI Biotech Holding ASA ('PCI Biotech') - Remuneration Report 2021". It details the remuneration principles, elements (fixed pay, variable pay, benefits), annual review of short-term incentives (bonus), long-term incentives (share options), pension scheme, and provides a detailed disclosure table for executive management remuneration for 2021 and 2020. This content directly corresponds to the definition of a Remuneration Report, which falls under the category of Remuneration Information (DEF 14A in the provided schema, although DEF 14A is typically a US proxy statement, the description for Remuneration Information matches the document content best). Given the specific focus on executive compensation disclosure, DEF 14A is the most appropriate code among the choices, even if the document is Norwegian in origin.
2022-05-04 English
Notice of Annual General Meeting 2022
Annual Report Classification · 100% confidence The document contains a comprehensive structure typical of an annual report, including a Board of Directors report, responsibility statements, corporate governance policies, financial statements, and an auditor's report. It covers the company's business areas, technology, and financial performance for the fiscal year 2021. Given the length and the inclusion of full financial statements and governance sections, it is classified as an Annual Report. FY 2021
2022-05-04 English
Notice of Annual General Meeting 2022
AGM Information Classification · 99% confidence The document explicitly states it contains 'PROPOSED RESOLUTIONS FOR THE ANNUAL GENERAL MEETING 25 May 2022'. It details agenda items typical of an AGM, such as election of chairperson, approval of accounts, election of the board of directors, determination of remuneration, and authorizations for capital increases. While it mentions the 'annual report' (Item 5), the primary context and structure are those of a meeting agenda and associated proposals, not the full report itself. This strongly indicates materials prepared for or presented at the Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R).
2022-05-04 English
Notice of Annual General Meeting 2022
AGM Information Classification · 100% confidence The document title explicitly states it contains proposals for the 'ÅRLIGE GENERALFORSAMLINGEN' (Annual General Meeting - AGM) on May 25, 2022. The content details specific agenda items (Sak 2 through Sak 11) which include approving the annual accounts, electing the board, setting remuneration, and granting mandates for capital increases, all typical items discussed and voted upon at an AGM. This strongly indicates the document is related to the AGM proceedings or the notice/proposals for it. The closest matching category is AGM Information (AGM-R). It is not a full 10-K (Annual Report) or an ER (Earnings Release), but rather the material presented for the meeting itself.
2022-05-04 English
Notice of Annual General Meeting 2022
AGM Information Classification · 100% confidence The document is explicitly titled "NOTICE OF ANNUAL GENERAL MEETING OF PCI BIOTECH HOLDING ASA" and details the date, time, location, and agenda for the meeting. It also includes appendices for the Notice of Attendance and Power of Attorney related to this meeting. This content directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the approval of the annual report (Item 5), the primary purpose and structure of the document is the notice and logistics for the Annual General Meeting.
2022-05-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.